Back to 
JPMorgan Chase & Co.
JPMorgan Chase & Co.
BBNX
6 quarters
Position history for JPMorgan Chase & Co.'s holdings in Beta Bionics, Inc.
Yes. JPMorgan Chase holds 703,356 shares of BBNX (Beta Bionics), worth $12M, as of its Q2 2026 13F filing. It increased the position by 396,127 shares (+128.9%) from Q1 2026. JPMorgan Chase has held BBNX in every 13F on record since Q1 2025, 6 quarterly filings.
Current Value
$12M
Current Shares
703,356
Total Value Change
+$11.9M
Total Shares Change
+697,096
Quarter-by-Quarter History
Other major holders of BBNX: Farallon Capital Management, L.L.C., Morgan Stanley, BlackRock, Inc., Wellington Management Group LLP